Dexrabeprazole

DB13762InvestigationalSmall molecule

Dexrabeprazole is a proton pump inhibitor indicated in the treatment of gastroesophageal reflux disease and gastrointestinal ulcers. A medication used to treat some forms of acid reflux and ulcers of the digestive system.

Chemical structure of Dexrabeprazole
Mechanism
Curator reviewed
Formula / weight
C18H21N3O3S · 359.443 g/mol (avg)
Also known as
Rabeprazole, (r)-

Resolves to

Compound
UNII65JK8810RMCAS177795-60-7ChEMBLCHEMBL1615209ChEBI134729
Clinical / RWD
ATCA02BC07
Structure
InChIKeyYREYEVIYCVEVJK-RUZDIDTESA-NSMILESCOCCCOC1=CC=NC(C[S@@](=O)C2=NC3=CC=CC=C3N2)=C1C
Targets
P20648ATP4A

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
282Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
5Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
10ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 1 country and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexrabeprazole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In